Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
1.
Hum Reprod ; 34(4): 770-779, 2019 04 01.
Article in English | MEDLINE | ID: mdl-30753444

ABSTRACT

STUDY QUESTION: Which Y genes mapped to the 'Gonadoblastoma Y (GBY)' locus on human Y chromosome are expressed in germ cells of individuals with some Differences of Sexual Development (DSD) and a Y chromosome in their karyotype (DSD-XY groups)? SUMMARY ANSWER: The GBY candidate genes DDX3Y and TSPY are expressed in the germ cells of DSD-XY patients from distinct etiologies: patients with mixed gonadal dysgenesis (MGD) and sex chromosome mosaics (45,X0/46,XY; 46,XX/46,XY); patients with complete androgen insensitivity (CAIS), patients with complete gonadal dysgenesis (CGD; e.g. Swyer syndrome). WHAT IS KNOWN ALREADY: A GBY locus was proposed to be present on the human Y chromosome because only DSD patients with a Y chromosome in their karyotype have a high-although variable-risk (up to 55%) for germ cell tumour development. GBY was mapped to the proximal part of the short and long Y arm. TSPY located in the proximal part of the short Y arm (Yp11.1) was found to be a strong GBY candidate gene. It is expressed in the germ cells of DSD-XY patients with distinct etiologies but also in foetal and pre-meiotic male spermatogonia. However, the GBY region extends to proximal Yq11 and therefore includes probably more than one candidate gene. STUDY DESIGN, SIZE, DURATION: Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy. Expression of OCT3/4 in the same tissue samples marks the rate of pluripotent germ cells. PARTICIPANTS/MATERIALS, SETTING, METHOD: A total of 145 DSD individuals were analysed for the Y chromosome to select the DSD-XY subgroup. PCR multiplex assays with Y gene specific marker set score for putative microdeletions in GBY Locus. Immunohistochemical experiments with specific antisera mark expression of the GBY candidate proteins, DDX3Y, TSPY, in serial sections of the gonadal tissue samples; OCT3/4 expression analyses in parallel reveal the pluripotent germ cell fraction. MAIN RESULTS AND THE ROLE OF CHANCE: Similar DDX3Y and TSPY protein expression patterns were found in the germ cells of DSD-XY patients from each subgroup, independent of age. In CAIS patients OCT3/4 expression was often found only in a fraction of these germ cells. This suggest that GBY candidate proteins are also expressed in the non-malignant germ cells of DSD-XY individuals like in male spermatogonia. LIMITATIONS, REASONS FOR CAUTION: Variation of the expression profiles of GBY candidate genes in the germ cells of some DSD-XY individuals suggests distinct transcriptional and translational control mechanisms which are functioning during expression of these Y genes in the DSD-XY germ cells. Their proposed GBY tumour susceptibility function to transform these germ cells to pre-malignant GB/Germ Cell Neoplasia in Situ (GB/GCNIS) cells seems therefore to be limited and depending on their state of pluripotency. WIDER IMPLICATIONS OF THE FINDINGS: These experimental findings are of general importance for each individual identified in the clinic with DSD and a Y chromosome in the karyotype. To judge their risk of germ cell tumour development, OCT3/4 expression analyses on their gonadal tissue section is mandatory to reveal the fraction of germ cells still being pluripotent. Comparative expression analysis of the GBY candidate genes can be helpful to reveal the fraction of germ cells with genetically still activated Y chromosomes contributing to further development of malignancy if at high expression level. STUDY FUNDING/COMPETING INTEREST(S): This research project was supported by a grant (01GM0627) from the BMBF (Bundesministerium für Bildung und Forschung), Germany to P.H.V. and B.B. The authors have no competing interests.


Subject(s)
Cell Cycle Proteins/metabolism , Chromosomes, Human, Y/metabolism , DEAD-box RNA Helicases/metabolism , Genetic Loci , Germ Cells/metabolism , Gonadoblastoma/genetics , Karyotype , Minor Histocompatibility Antigens/metabolism , Ovarian Neoplasms/genetics , Testicular Neoplasms/genetics , Adolescent , Adult , Biopsy , Cell Cycle Proteins/genetics , Child , Child, Preschool , DEAD-box RNA Helicases/genetics , Female , Gene Expression Regulation, Neoplastic , Gonadoblastoma/blood , Gonadoblastoma/pathology , Gonads/pathology , Humans , Infant , Male , Minor Histocompatibility Antigens/genetics , Ovarian Neoplasms/blood , Ovarian Neoplasms/pathology , Testicular Neoplasms/blood , Testicular Neoplasms/pathology , Young Adult
3.
Nat Genet ; 6(3): 245-50, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8012385

ABSTRACT

Breeding the Y chromosome from certain Mus musculus domesticus strains onto the inbred laboratory mouse strain, C57BL/6J (B6), results in hermaphroditic progeny. This strain-dependent sex reversal suggests that there may be significant allelic variation in the murine sex determining gene, Sry. We have analysed the Sry genes from several domesticus-type Y chromosomes and show that they encode smaller proteins than the molossinus-type alleles SryB6 and Sry129. We have also identified a polymorphic stretch of trinucleotide repeats that is unique to strains causing sex reversal and show that specific changes in the predicted polyglutamine amino acid sequence at this site are associated with different degrees of sex reversal.


Subject(s)
Disorders of Sex Development , Nuclear Proteins , Polymorphism, Genetic , Repetitive Sequences, Nucleic Acid , Transcription Factors , Amino Acid Sequence , Animals , Base Sequence , DNA/genetics , DNA Primers/genetics , DNA-Binding Proteins/genetics , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Molecular Sequence Data , Oligodeoxyribonucleotides/genetics , Sequence Homology, Amino Acid , Sex Determination Analysis , Sex-Determining Region Y Protein , Y Chromosome
4.
Science ; 243(4887): 80-3, 1989 Jan 06.
Article in English | MEDLINE | ID: mdl-2563174

ABSTRACT

Isolation and mapping of a mouse complementary DNA sequence (mouse Y-finger) encoding a multiple, potential zinc-binding, finger protein homologous to the candidate human testis-determining factor gene is reported. Four similar sequences were identified in Hind III-digested mouse genomic DNA. Two (7.2 and 2.0 kb) were mapped to the Y chromosome. Only the 2.0-kb fragment, however, was correlated with testis determination. Polymerase chain reaction analysis suggests both Y loci are transcribed in adult testes. A 3.6-kb fragment was mapped to the X chromosome between the T16H and T6R1 translocation breakpoints, and a fourth (6.0 kb) was mapped to chromosome 10. Hence, mYfin sequences have been duplicated several times in the mouse, although they are not duplicated in humans.


Subject(s)
Chromosome Mapping , Genes , Sex Determination Analysis , Testis/anatomy & histology , Transcription, Genetic , Animals , DNA-Binding Proteins/genetics , Male , Metalloproteins/genetics , Mice , Nucleic Acid Hybridization , Polymorphism, Restriction Fragment Length , X Chromosome , Y Chromosome
6.
Mol Cell Biol ; 13(7): 4323-30, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8321234

ABSTRACT

A cDNA encoding a DNA-binding protein has been isolated by screening a mouse testicular expression cDNA library with a concatemer of a 12-bp putative protein-binding element present in the promoter of the testis-specific gene PGK-2. Sequence analysis of the isolated cDNA indicated the presence of an open reading frame that encodes a protein with two conserved DNA-binding motifs known as the high-mobility-group (HMG) boxes. Northern (RNA) blot analysis demonstrated that expression of the gene is restricted to the postpuberal testis. The DNA-binding activity and sequence specificity of the recombinant HMG protein were confirmed by DNA mobility shift assay using the initial concatemer of the PGK-2 promoter element as a probe as well as the wild-type or mutated versions of the 12-bp element within its natural sequence context. Immunocytochemical staining of adult testis sections with polyclonal antisera recognizing this recombinant HMG protein demonstrated that it is located predominantly in the nuclei of elongated spermatids at steps 9 and 10. These results suggest that this novel HMG box protein gene may be involved in the regulation of gene expression of the haploid male genome. The gene from which the cDNA was derived has been termed testis-specific HMG (tsHMG).


Subject(s)
DNA-Binding Proteins/genetics , High Mobility Group Proteins/genetics , Spermatids/chemistry , Testis/metabolism , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Nucleus/chemistry , Chromatin/metabolism , Conserved Sequence , DNA , DNA-Binding Proteins/metabolism , High Mobility Group Proteins/metabolism , Male , Mice , Molecular Sequence Data , Open Reading Frames , Organ Specificity/genetics , Spermatids/growth & development , Spermatids/ultrastructure , Transcription, Genetic
7.
Mol Cell Biol ; 4(8): 1469-75, 1984 Aug.
Article in English | MEDLINE | ID: mdl-6493227

ABSTRACT

We studied the effects of gene amplification on human globin gene expression in Chinese hamster ovary cells. The normal human alpha-globin gene (N alpha 2) and a hybrid gene (M alpha G) containing the 5' promoter-regulator region of the mouse metallothionein gene and the human structural alpha 2-globin gene were linked to a modular SV2-cDNA dihydrofolate reductase (DHFR) gene. The recombinant DNA molecules were introduced into Chinese hamster ovary cells by calcium phosphate precipitation. After initial selection to retain the DHFR and linked sequences, the cells were cultured in increasing concentrations of methotrexate up to 0.2 mM. Southern blot analysis of total cellular DNA showed an approximately 500- to 1,000-fold increase in the number of copies of DHFR and human alpha-globin genes. The transcription of the alpha-globin and DHFR genes increased as their copy number within the cells increased. The transcription of the amplified hybrid M alpha G gene was also inducible with cadmium treatments. Both mature mRNA and "read-through" transcripts were observed. DHFR constituted approximately 10% of pulse-labeled cellular proteins in these cells, but no human alpha-globin was detected. In vitro translation of polyadenylated RNA from these cells showed that alpha-globin mRNA transcribed from the amplified alpha-globin genes was functional and directed alpha-globin chain synthesis. In situ hybridization of 3H-labeled alpha-globin and DHFR DNA probes in chromosome preparations from the two cell lines indicated that both genes were coamplified in the same chromosomal locations in each cell type. These results indicate that gene amplification enhances human globin gene expression in cultured Chinese hamster ovary cells.


Subject(s)
Gene Amplification , Genes , Globins/genetics , Promoter Regions, Genetic , Animals , Cadmium/pharmacology , Cell Line , Cricetinae , Cricetulus , Female , Genetic Linkage , Humans , Methotrexate/toxicity , Mutation , Ovary , Protein Biosynthesis , RNA, Messenger/genetics , Tetrahydrofolate Dehydrogenase/genetics , Transcription, Genetic
8.
Mol Cell Biol ; 7(9): 3107-12, 1987 Sep.
Article in English | MEDLINE | ID: mdl-2823118

ABSTRACT

In both humans and mice, two genes encode phosphoglycerate kinase, a key enzyme in the glycolytic pathway. The pgk-1 gene is expressed in all somatic cells, is located on the X chromosome, and contains 10 introns. The pgk-2 gene is expressed only in sperm cells, is located on an autosome, and has no introns. The nucleotide sequence of the pgk-2 gene suggests that it arose from pgk-1 more than 100 million years ago by RNA-mediated gene duplication. The pgk-2 gene may, then, be a transcribed retroposon. Thus, gene duplication by retroposition may have been used as a mechanism for evolutionary diversification.


Subject(s)
Phosphoglycerate Kinase/genetics , Testis/physiology , Amino Acid Sequence , Animals , Base Sequence , Biological Evolution , Chromosome Mapping , DNA/genetics , DNA Restriction Enzymes , Gene Expression Regulation , Genes , Male , Mice , Molecular Sequence Data , RNA, Messenger/genetics , Testis/enzymology , Transcription, Genetic
9.
Mol Endocrinol ; 9(12): 1645-54, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8614401

ABSTRACT

The Sry gene functions as a genetic switch initiating testicular development of the indifferent mammalian gonad. The Mus musculus molossinus Sry open reading frame (ORF) encodes a 395-amino acid transcription factor (mSry) that specifically binds and bends DNA through its N-terminal HMG domain and activates transcription through its long C-terminal (residues 144-366) glutamine/histidine-rich activation domain. The M. m. domesticus Sry ORF encodes a highly homologous, truncated protein (dSry) of approximately 230 amino acids, and the molecular basis for truncation is a point mutation that creates an amber stop codon within the activation domain. The mSry protein activates transcription of a Sry-responsive reporter gene in HeLa cells, but dSry does not. Gene swapping and in vitro DNA binding experiments revealed that lack of transcriptional activation by dSry was not the result of polymorphisms within the first 137 amino acids of the protein. Direct analysis of the C-terminal glutamine/histidine-rich domain revealed that dSry lacked a functional transcriptional activation domain. Fusion of the GAL4 DNA-binding domain to the C-terminal deletion mutants of the GAL4-mSry chimeric protein indicated that residues 263-345 of the glutamine/histidine-rich domain were necessary for high level transactivation. Furthermore, readthrough of the premature amber stop codon by transfer RNA suppression resulted in a strong GAL4-dSry transactivator. This demonstrated that the premature stop codon is the only polymorphism responsible for the inability of the dSry glutamine/histidine-rich region to transactivate.


Subject(s)
DNA-Binding Proteins/genetics , Mice/genetics , Nuclear Proteins , Saccharomyces cerevisiae Proteins , Transcription Factors , Animals , Base Sequence , Binding Sites , CHO Cells , Cricetinae , DNA/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Genes, Reporter , HeLa Cells , Humans , Open Reading Frames , Sex Determination Analysis , Sex-Determining Region Y Protein , Transcriptional Activation , Transfection
10.
Int J Dev Biol ; 43(3): 219-27, 1999 May.
Article in English | MEDLINE | ID: mdl-10410901

ABSTRACT

The Q-rich domain of the mouse sex determining gene, Sry, is encoded by an in-frame insertion of a repetitive sequence composed of mostly CAG repeats. The exact function of this Q-rich domain is unknown. Studies on the polymorphisms within this Q-rich domain among different domesticus and musculus mouse strains suggest a possible role for this domain in sex determination. Using the farwestern protein-blotting technique and recombinant fusion proteins containing the Sry Q-rich domain as probes, three Sry interactive proteins of 94, 32 and 28 kDa apparent molecular weight (Sip-1, -2 and -3 respectively) were consistently detected in adult testis. Sip expression was detected in somatic cells and was associated with the spermatogenic activity of the testis. During embryogenesis, Sips were readily detected in total tissue extracts of embryos as early as E8.5 day. In fetal gonads of both sexes, their expression peaked around E11.5-13.5 day, at the time of sex determination and differentiation, and decreased drastically towards late stages of gestation. These observations support the hypothesis that the Q-rich domain may contribute to the biological function(s) of mouse Sry through a protein-protein interactive role(s).


Subject(s)
DNA-Binding Proteins/genetics , Gene Expression Regulation, Developmental , Sex Determination Processes , Animals , Female , Male , Mice , Nuclear Proteins/genetics , Sex-Determining Region Y Protein , Spermatogenesis/genetics , Testis/physiology , Transcription Factors/genetics
11.
Gene ; 46(2-3): 277-86, 1986.
Article in English | MEDLINE | ID: mdl-3468045

ABSTRACT

We have constructed two new recombinant cosmid vectors that can be used for direct expression and amplification of genomic DNA in mammalian cells. The vectors allow cloning of DNA fragments up to 40 kb in size. Each carries two dominant selectable markers: the bacterial neo gene and the mouse DHFR gene. In the first vector, pCV001, the neo and DHFR genes are regulated by the SV40 early promoter, and in the second, pAVCV007, by the avian sarcoma virus LTR promoter. The neo gene served as a dominant marker for the selection of transformants in all mammalian cell types, and we demonstrate here that the LTR promoter significantly improved the efficiency of DNA-mediated transformation of a human cell line. We isolated the human growth hormone genes from genomic libraries prepared in these cosmid vectors and used these recombinant cosmids for direct transfections of cultured cells. Selection of transformants in increasing concentrations of methotrexate led to the outgrowth of resistant cell populations carrying amplified copies of the DHFR marker. A 40-1000-fold coamplification of the hGH genes was observed in the different transfected cell lines, along with a corresponding increase in transcription and translation activity of the hGH gene. Gene amplification could be achieved in both DHFR deficient or normal cell lines. High level expression of a cloned gene mediated by gene amplification should facilitate characterization of DNA sequences, as well as isolation of specific gene products for biochemical, functional, and pharmacological studies.


Subject(s)
Cosmids , Gene Amplification , Genetic Vectors , Growth Hormone/genetics , Animals , Cells, Cultured , Chromosome Mapping , Cloning, Molecular , Gene Expression Regulation , Genes, Bacterial , Genetic Markers , Humans , Mice , Tetrahydrofolate Dehydrogenase/genetics , Transformation, Genetic
12.
Gene ; 57(1): 53-9, 1987.
Article in English | MEDLINE | ID: mdl-2828182

ABSTRACT

We have constructed a plasmid vector pSV2neo-MK alpha G in which the structural tk gene for Herpes simplex virus thymidine kinase (HSV-TK) was placed downstream from the metallothionein-I promoter. The vector also contained the selection marker aminoglycoside 3'-phosphotransferase (Km). This vector was able to transform the filamentous fungus Achlya ambisexualis and G-418-resistant colonies were obtained. Southern blot analyses revealed that multiple bands hybridizing to the HSV tk gene probe were present in the genomic DNA of the transformants. Upon analysis by gel electrophoresis, one of the transformants exhibited TK activity bearing electrophoretic mobility similar to that of the HSV-TK. An increase of approx. 40% of [3H]thymidine uptake and incorporation into cellular DNA was also observed in this transformant. This study suggested that the HSV tk gene can be expressed in the fungus A. ambisexualis that can be considered as a candidate host cell for further gene-expression studies.


Subject(s)
Chytridiomycota/genetics , Genes, Viral , Genes , Oomycetes/genetics , Simplexvirus/genetics , Thymidine Kinase/genetics , Cloning, Molecular , DNA Restriction Enzymes , Genetic Vectors , Metallothionein/genetics , Plasmids , Promoter Regions, Genetic , Simplexvirus/enzymology , Thymidine/metabolism , Transcription, Genetic
13.
Methods Enzymol ; 303: 349-80, 1999.
Article in English | MEDLINE | ID: mdl-10349654

ABSTRACT

A new and highly effective method, termed suppression subtractive hybridization (SSH), has been developed for the generation of subtracted cDNA libraries. It is based primarily on a technique called suppression PCR, and combines normalization and subtraction in a single procedure. The normalization step equalizes the abundance of cDNAs within the target population and the subtraction step excludes the common sequences between the target and driver populations. As a result only one round of subtractive hybridization is needed and the subtracted library is normalized in terms of abundance of different cDNAs. It dramatically increases the probability of obtaining low-abundance differentially expressed cDNA and simplifies analysis of the subtracted library. The SSH technique is applicable to many molecular genetic and positional cloning studies for the identification of disease, developmental, tissue-specific, or other differentially expressed genes. This chapter provides detailed protocols for the generation of subtracted cDNA and differential screening of subtracted cDNA libraries. As a representative example we demonstrate the usefulness of the method by constructing a testis-specific cDNA library as well as using the subtracted cDNA mixture as a hybridization probe. Finally, we discuss the characteristics of subtracted libraries, the nature and level of background nondifferentially expressed clones in the libraries, as well as a procedure for the rapid identification of truly differentially expressed cDNA clones.


Subject(s)
Chromosome Mapping/methods , DNA, Complementary/biosynthesis , Gene Library , Nucleic Acid Hybridization/methods , Polymerase Chain Reaction/methods , Animals , Base Sequence , Cloning, Molecular/methods , DNA Primers , DNA, Complementary/analysis , Gene Expression , Humans , Indicators and Reagents , Male , Mammary Tumor Virus, Mouse/genetics , Mice , Restriction Mapping/methods , Testis/metabolism , Y Chromosome
14.
Cytogenet Genome Res ; 101(3-4): 237-41, 2003.
Article in English | MEDLINE | ID: mdl-14684989

ABSTRACT

Protein transduction is a powerful tool to deliver biologically active protein into mammalian cells and whole animals. Transduced proteins are folded properly and can mediate their respective functions in their hosts. To examine the feasibility of applying this strategy to study the molecular events of gonadogenesis, we have studied the kinetics of protein transduction and stability of transduced protein in in vitro mouse gonad culture systems using two reporter proteins, TAT-beta-gal and beta-gal fusion proteins with and without the TAT protein transduction domain (PTD) respectively. Our results indicate that the TAT-PTD was critical and essential for protein transduction to cultured fetal gonads. The TAT-beta-gal reporter entered the cells of the gonads and mesonephros efficiently for both sexes at E11.5 to E15.5 stages examined. The delivered protein persisted in the gonads for an extended period after an initial one-hour transduction. The distribution of the reporter was relatively even in gonads and mesonephros at E11.5 stage for both sexes and at later stages in female. The transduced protein was distributed heterogeneously in male gonads after seminiferous tubule differentiation in which the amount of reporter protein was higher outside than inside the tubules. Nevertheless, we surmise that such protein delivery technique should be useful in studies designed to evaluate the sex determining or differentiating functions of various new protein factors identified by advanced differential screening strategies.


Subject(s)
Protein Transport , Sex Determination Analysis/methods , Sex Differentiation , Animals , Cells, Cultured , Female , Gonads/anatomy & histology , Gonads/embryology , Gonads/metabolism , Kinetics , Male , Mammals , Mice , Recombinant Fusion Proteins/metabolism
15.
Cytogenet Genome Res ; 101(3-4): 250-60, 2003.
Article in English | MEDLINE | ID: mdl-14684991

ABSTRACT

The contribution of specific genes on the Y chromosome in the etiology of prostate cancer has been undefined. Genetic mapping studies have identified a gonadoblastoma locus on the human Y chromosome (GBY) that predisposes the dysgenetic gonads of XY sex-reversed patients to tumorigenesis. Recently a candidate gene, the testis-specific protein Y-encoded (TSPY) that resides on the GBY critical region, has been demonstrated to express preferentially in tumor cells in gonadoblastoma and testicular germ cell tumors. TSPY shares high homology to a family of cyclin B binding proteins and has been considered to possibly play a role in cell cycle regulation or cell division. To address the possible involvement of the TSPY gene in prostate cancer, both in situ mRNA hybridization and immunohistochemistry techniques were used to study the expression of this putative GBY gene in prostate specimens. Our results demonstrated that TSPY was expressed at low levels in normal epithelial cells and benign prostatic hyperplasia (BPH), but at elevated levels in tumor cells of prostate cancers at various degrees of malignancy. Sequence analysis of RT-PCR products obtained from both prostatic and testicular tissues using specific primers flanking the open reading frame of the TSPY mRNA revealed a complex pattern of RNA processing of the TSPY transcripts involving cryptic intron splicing and/or intron skipping. The variant transcripts encode a variety of polymorphic isoforms or shortened versions of the TSPY protein, some of which might possess different biochemical and/or functional properties. The abbreviated transcripts were more abundant in prostatic cancer tissues than the testicular ones. Although the exact nature of such variant TSPY transcripts and proteins is still unclear, their differential expression suggests that the TSPY gene may also be involved in the multi-step prostatic oncogenesis besides its putative role in gonadoblastoma and testicular seminoma.


Subject(s)
DNA-Binding Proteins/metabolism , Nuclear Proteins , Prostatic Neoplasms/metabolism , Transcription Factors , Alternative Splicing , Amino Acid Sequence , Cell Cycle Proteins , Chromosomes, Human, Y , DNA-Binding Proteins/genetics , Gene Expression , Genetic Predisposition to Disease , Gonadoblastoma/genetics , Humans , Male , Molecular Sequence Data , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/metabolism , Sequence Alignment , Sex-Determining Region Y Protein , Testicular Neoplasms/genetics
16.
Am J Med Genet ; 70(2): 134-7, 1997 May 16.
Article in English | MEDLINE | ID: mdl-9128931

ABSTRACT

Here we describe the first reported case of a patient with a familial paracentric inversion in the long arm of the Y chromosome and ambiguous genitalia. FISH analyses with Y chromosome YACs demonstrated that the inversion breakpoints of the patients and the father's Ys appear to be the same and lie within interval 5B of the Y chromosome. PCR and sequence analysis indicated that our patient carries a normal SRY gene. For an additional comparison of the patient's inv(Y) with the father, two other Y chromosome sequences were examined. Molecular studies of this familial inverted Y chromosome showed no differences in the ZFY and TSPY genes between the father and the patient suggesting that the short arm of our patient's inv(Y) is identical to that of the patient's father. Southern analysis using a probe of the DAX-1 gene indicated that a single copy of DSS (dosage sensitive sex reversal) locus was present in the patient. Our results suggest that the abnormal sexual development in our patient is likely attributable to (an)other mechanism(s) than mutation in the SRY gene and dosage alteration of the DAX-1 gene.


Subject(s)
Chromosome Inversion , Disorders of Sex Development , Gonadal Dysgenesis, 46,XY/genetics , Y Chromosome/genetics , Humans , In Situ Hybridization, Fluorescence , Infant, Newborn , Male
17.
J Reprod Immunol ; 21(3): 275-91, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1522559

ABSTRACT

Several cDNA clones of a gene termed male-enhanced antigen-2 (Mea-2), have been isolated from a mouse testicular expression cDNA library using a monoclonal histocompatability Y (H-Ys) antibody which detects specific protein(s) present in the mouse testis but not the ovary. The Mea-2 gene is phylogenetically conserved among various mammalian species examined, and is expressed at high levels in adult mouse testis. The expression pattern of Mea-2 is very similar to that of another gene, the male-enhanced antigen-1 (Mea-1), previously isolated using a polyclonal H-Ys antibody. Northern blotting and RT-PCR analyses demonstrated that Mea-2 is also expressed in other adult and fetal mouse organs at low levels. The testis-enhanced expression of this gene is associated with germ cell development at mid- to late-meiotic stages of spermatogenesis. Analysis of an intersubspecies mouse backcross has assigned this gene to chromosome 5, between the loci Gus and Hnf-1.


Subject(s)
Antibodies, Monoclonal/immunology , H-Y Antigen/immunology , Proteins/genetics , Animals , Antibody Specificity , Base Sequence , Chromosome Mapping , Cricetinae , Cricetulus , DNA/genetics , Female , Guinea Pigs , Humans , Male , Mice , Mice, Inbred C57BL/genetics , Molecular Sequence Data , Ovary/immunology , Phylogeny , Proteins/immunology , Rats , Sequence Homology, Nucleic Acid , Species Specificity , Testis/chemistry , Testis/immunology
18.
J Hum Hypertens ; 26(10): 563-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22129612

ABSTRACT

Hypertension is one of the most important risk factors associated with atrial fibrillation (AF) and increased the risk of cardiovascular events in patients with AF. However, the pathophysiological link between hypertension and AF is unclear. Nevertheless, this can be explained by the hemodynamic changes of the left atrium secondary to long standing hypertension, resulting in elevated left atrium pressure and subsequently left atrial enlargement. Moreover, the activation of renin-angiotensin-aldosterone system (RAAS) activation in patients with hypertension induces left atrial fibrosis and conduction block in the left atrium, resulting in the development of AF. Accordingly, recent studies have shown that effective blockage of RAAS by angiotensin converting enzyme inhibitors or angiotensin receptor antagonist may be effective in both primary and secondary prevention of AF in patients with hypertension, although with controversies. In addition, optimal antithrombotic therapy, blood pressure control as well as rate control for AF are key to the management of patients with AF.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/drug therapy , Hypertension/complications , Renin-Angiotensin System/drug effects , Angiotensin Receptor Antagonists/therapeutic use , Atrial Fibrillation/epidemiology , Atrial Fibrillation/etiology , Atrial Fibrillation/prevention & control , Blood Pressure , Humans , Hypertension/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL